Search - tctmd.com

Displaying 1 - 20 of 99

Sort: Relevancy | Date

News Daily News

Efraín Gaxiola López, Mexican Society of Cardiology President and CADECI Founder, Dies at 62

Yael L. Maxwell

December 17, 2025

Presentation TCT 2025

TCT 1424: Transcatheter Aortic Valve Replacement (TAVR) With JenaValve Trilogy System for Aortic Regurgitation Following a David Procedure

Presenter: Chih-Fan Yeh

October 28, 2025

Presentation TCT 2025

TCT 1423: Transcatheter Rescue in the Setting of Endocarditis: Emergency-Use JenaValve in a Non-Surgical Candidate

Presenter: Ankit Gauba

October 28, 2025

Presentation NY Valves 2025

The Effect of Transcatheter Aortic Valve Replacement With JenaValve Trilogy on 1-Year Reverse Remodeling in Patients With Pure Aortic Regurgitation Stratified by Baseline LV Function

Presenter: Lauren Sharan Ranard

June 27, 2025

Presentation NY Valves 2025

The JenaValve TAVR System: Lessons Learned from the Continued Access Study

Presenter: Raj Makkar

June 26, 2025

Presentation NY Valves 2025

Use of JenaValve in a Young Female With Severe Aortic Regurgitation and Takayasu Arteritis

Presenter: Ankit Gauba

June 25, 2025

News Conference News ACC 2025

More ALIGN-AR Data Bolster Potential for a Dedicated AR Device

Yael L. Maxwell

March 30, 2025

News Daily News

Top Structural Heart News of 2024

L.A. McKeown

December 29, 2024

News Conference News TCT 2024

ALIGN-AR at 2 Years Shows Promise for TAVI With Trilogy in Aortic Regurgitation

Yael L. Maxwell

October 29, 2024

Presentation TCT 2024

The ALIGN-AR Trial: Two-Year Outcomes of Transcatheter Aortic Valve Replacement With JenaValve TrilogyTM in High Surgical Risk Patients With Moderate-to-Severe or Severe Native Aortic Regurgitation

Presenter: Torsten Vahl

October 29, 2024

Presentation TCT 2024

Experience With JenaValve – Technology, Case Examples, and Clinical Trials

Presenter: Raj Makkar

October 28, 2024

News Conference News NY Valves 2024

Dedicated Devices for Aortic Regurgitation Supported by Meta-analysis

Todd Neale

June 13, 2024

Presentation NY Valves 2024

Hemodynamic Performance of the JenaValve Trilogy™ System in Patients With Severe Aortic Valve Stenosis: Insights From ALIGN-AS and Commercial Experience

Presenter: Matti Adam

June 07, 2024

Presentation NY Valves 2024

The Effect of Baseline Left Ventricular Ejection Fraction on Reverse Remodeling After Jenavalve Trilogy Transcatheter Aortic Valve Replacement in Patients With Pure Aortic Regurgitation: An Analysis From the ALIGN-AR Trial

Presenter: Lauren Sharan Ranard

June 07, 2024

Presentation NY Valves 2024

JenaValve

Presenter: Raj Makkar

June 06, 2024

Presentation NY Valves 2024

JenaValve Following Previous Ross Procedure

Presenter: Daniel Zumerkorn Hassan

June 06, 2024

News Features

After DanGer Shock’s Win in AMICS for Impella: What’s Next?

Caitlin E. Cox

May 02, 2024

News Daily News

Top Structural Heart News of 2023

Todd Neale

January 02, 2024

News Daily News

Ross Procedure Offers ‘Excellent Survival’ 25 Years Out

Caitlin E. Cox

November 15, 2023

News Conference News TCT 2023

ALIGN-AR: Positive Results for Trilogy Valve in Aortic Regurgitation

Todd Neale

October 26, 2023

Advertisement

Efraín Gaxiola López, Mexican Society of Cardiology President and CADECI Founder, Dies at 62

TCT 1424: Transcatheter Aortic Valve Replacement (TAVR) With JenaValve Trilogy System for Aortic Regurgitation Following a David Procedure

TCT 1423: Transcatheter Rescue in the Setting of Endocarditis: Emergency-Use JenaValve in a Non-Surgical Candidate

The Effect of Transcatheter Aortic Valve Replacement With JenaValve Trilogy on 1-Year Reverse Remodeling in Patients With Pure Aortic Regurgitation Stratified by Baseline LV Function

The JenaValve TAVR System: Lessons Learned from the Continued Access Study

Use of JenaValve in a Young Female With Severe Aortic Regurgitation and Takayasu Arteritis

More ALIGN-AR Data Bolster Potential for a Dedicated AR Device

Top Structural Heart News of 2024

ALIGN-AR at 2 Years Shows Promise for TAVI With Trilogy in Aortic Regurgitation

The ALIGN-AR Trial: Two-Year Outcomes of Transcatheter Aortic Valve Replacement With JenaValve TrilogyTM in High Surgical Risk Patients With Moderate-to-Severe or Severe Native Aortic Regurgitation

Experience With JenaValve – Technology, Case Examples, and Clinical Trials

Dedicated Devices for Aortic Regurgitation Supported by Meta-analysis

Hemodynamic Performance of the JenaValve Trilogy™ System in Patients With Severe Aortic Valve Stenosis: Insights From ALIGN-AS and Commercial Experience

The Effect of Baseline Left Ventricular Ejection Fraction on Reverse Remodeling After Jenavalve Trilogy Transcatheter Aortic Valve Replacement in Patients With Pure Aortic Regurgitation: An Analysis From the ALIGN-AR Trial

JenaValve

JenaValve Following Previous Ross Procedure

After DanGer Shock’s Win in AMICS for Impella: What’s Next?

Top Structural Heart News of 2023

Ross Procedure Offers ‘Excellent Survival’ 25 Years Out

ALIGN-AR: Positive Results for Trilogy Valve in Aortic Regurgitation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content